Please use this identifier to cite or link to this item:
Title: Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].
Austin Authors: Reck, M;Ciuleanu, T-E;Cobo, M;Schenker, M;Zurawski, B;Menezes, J;Richardet, E;Bennouna, J;Felip, E;Juan-Vidal, O;Alexandru, A;Sakai, H;Lingua, A;Reyes, F;Souquet, P-J;De Marchi, P;Martin, C;Pérol, M;Scherpereel, A;Lu, S;Paz-Ares, L;Carbone, D P;Memaj, A;Marimuthu, S;Zhang, X;Tran, P;John, Thomas 
Affiliation: Medical Oncology
Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany. Electronic address:
Department of Oncology, Institutul Oncologic Prof Dr Ion Chiricuta and UMF Iuliu Hatieganu, Cluj-Napoca, Romania
Department of Medical Oncology, Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain
Department of Oncology, SF Nectarie Oncology Center, Craiova, Romania
Department of Clinical Oncology, Ambulatorium Chemioterapii, Bydgoszcz, Poland
Department of Oncology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil
Department of Clinical Oncology, Instituto Oncológico de Córdoba, Córdoba, Argentina
Department of Thoracic Oncology, University Hospital of Nantes and INSERM, CRCINA, Nantes, France
Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain
Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain
Department of Oncology, Institute of Oncology Prof Dr Alexandru Trestioreanu Bucha, Bucharest, Romania
Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan
Department of Medical Oncology, Instituto Medico Rio Cuarto, SA, Córdoba, Argentina
Department of Medical Oncology, Fundación Arturo López Pérez, Santiago, Metropolitana, Chile
Department of Pneumology, Hôpital Lyon Sud, Lyon, Pierre Bénite, France
Department of Oncology, Barretos Cancer Hospital, Barretos, Brazil
Department of Thoracic Oncology, Instituto Alexander Fleming, Buenos Aires, Argentina
Department of Thoracic Oncology, Léon Bérard Cancer Center, Lyon, France
Department of Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, OncoThAI, Lille, France
Department of Medical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China
Department of Medical Oncology, Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Clinical Research Unit, Universidad Complutense & CiberOnc, Madrid, Spain
Department of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA
Bristol Myers Squibb, Princeton, USA
Issue Date: 2-Dec-2021
Date: 2021-12-02
Publication information: ESMO Open 2021; 6(6): 100345
DOI: 10.1016/j.esmoop.2021.100345
Journal: ESMO Open
PubMed URL: 34864501
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 5, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.